XML 93 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6 - Acquisition
12 Months Ended
Dec. 31, 2012
Notes  
Note 6 - Acquisition

Note 6 – Acquisition

 

On March 18, 2011, UTMD purchased all of the common shares of Femcare Holdings Ltd (Femcare) of the United Kingdom, and its subsidiaries.  The acquisition was accretive to financial performance in 2012 and 2011. 

 

A one-year measurement period was initially established during which UTMD could make residual adjustments to valuations of assets and liabilities. During 2011, residual adjustments to initial valuations for prepaid expenses, goodwill and accrued expenses were made, but no adjustment was made to the purchase price or the value of identifiable intangibles. The adjustment period has expired.

 

A two-year escrow was set aside from the purchase price to back the warranties and representations of the sellers. No claims against the escrow have been made by UTMD.

 

The March 18, 2011 purchase price was allocated as follows:

 

 

 

 

 

Assets Acquired

 

 

Accounts receivable

$

2,176

Prepaid expenses

 

773

Inventory

 

1,319

Property and equipment

 

606

Identifiable intangibles

 

 

Patents

 

97

Non-compete agreements

 

162

Trademarks, trade names

 

11,559

Customer relationships

 

11,559

Regulatory approvals & product certifications

 

15,419

Goodwill

 

8,249

Total assets acquired

 

51,919

 

 

 

Liabilities Assumed

 

 

Accounts payable

 

1,107

Accrued expenses

 

644

Deferred tax liability

 

9,084

Total liabilities assumed

 

10,835

 

 

 

Net assets acquired

$

41,084

 

 

 

Pro forma Information

Revenue and net income of the combined entity as though the business combination occurred as of the beginning of the reporting period is:

 

 

 

Year ended

December 31, 2012 (as reported)

 

 

Year ended

December 31, 2011

Revenue

$

41,552

 

$

41,780

Net income

 

10,169

 

 

8,235

 

Pro forma net income of $8,235 for the year ended December 31, 2011 does not include $341 in UTMD legal costs directly attributable to the acquisition, and $1,765 in Femcare expenses for employee shareholder bonuses, loan redemption premium related to termination of ownership, buy-out of warrants, financial advisory fees and an insurance premium for sellers’ liability which are directly attributable to the acquisition.